Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-02-04

FDA Approved: OLANZAPINE AND FLUOXETINE — Supplemental Application (Par Health USA, LLC)

View source ↗

Summary

The FDA approved a supplemental application for a generic fixed-dose combination of olanzapine and fluoxetine from Par Health USA, LLC. The product is intended …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Olanzapine and fluoxetine (olanzapine; fluoxetine)

Snippet

SUPPL AP for OLANZAPINE AND FLUOXETINE (OLANZAPINE AND FUOXETINE)